“The Applicant evaluated the safety of adagrasib in GLP-compliant 28-day and 13-week repeat-dose toxicology studies in Sprague-Dawley rats and Beagle dogs, using the intended oral route of administration.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗
Why that species
Selected based on in vitro and in vivo metabolism studies
“The rat and dog were selected as preclinical species for toxicology studies based on results from in vitro and in vivo metabolism studies, which is supported.”
“The Applicant evaluated the safety of adagrasib in GLP-compliant 28-day and 13-week repeat-dose toxicology studies in Sprague-Dawley rats and Beagle dogs, using the intended oral route of administration.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗